AAD  Vol.2 No.2 , June 2013
Advances in Alzheimer’s disease (AAD): Standing firm at its first anniversary
Author(s) Xiao-Xin Yan*
ABSTRACT
Editorial: Advances in Alzheimer’s disease (AAD): Standing firm at its first anniversary
KEYWORDS
Editorial; AAD

Cite this paper
(2013) Advances in Alzheimer’s disease (AAD): Standing firm at its first anniversary. Advances in Alzheimer's Disease, 2, 49-50. doi: 10.4236/aad.2013.22006.
References
[1]   Hampel, H., Prvulovic, D., Teipel, S., Jessen, F., Luck-haus, C., Frolich, L., Riepe, M.W., Dodel, R., Leyhe, T., Bertram, L., Hoffmann, W. and Faltraco, F. (2011) The future of Alzheimer’s disease: The next 10 years. Progress in Neurobiology, 95, 718-728. doi:10.1016/j.pneurobio.2011.11.008

[2]   Contino, M., Cantore, M., Leopoldo, M. and Colabufo, N.A. (2013) Biomarkers for the early diagnosis of Alzheimer’s disease: The challenge of XXI century. Advances in Alzheimer’s Disease, 1, 13-30. doi:10.4236/aad.2013.21003

[3]   Braak, H. and Del Tredici, K. (2012) Where, when, and in what form does sporadic Alzheimer’s disease begin? Current Opinion in Neurology, 25, 708-714. doi:10.1097/WCO.0b013e32835a3432

[4]   Cai, Y., Xiong, K., Zhang, X.M., Cai, H., Luo, X.G., Feng, J.C., Clough, R.W., Struble, R.G., Patrylo, P.R., Chu, Y., Kordower, J.H. and Yan, X.X. (2010) β-Secretase-1 elevation in aged monkey and Alzheimer’s disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation. European Journal of Neuroscience, 32, 1223-1238. doi:10.1111/j.1460-9568.2010.07376.x

[5]   Radak, Z., Hart, N., Sarga, L., Koltai, E., Atalay, M., Ohno, H. and Boldogh, I. (2010) Exercise plays a preventive role against Alzheimer’s disease. Journal of Alzheimers Disease, 20, 777-783.

[6]   Stern, Y. (2012) Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neu-rology, 11, 1006-1012. doi:10.1016/S1474-4422(12)70191-6

[7]   Skaper, S.D. (2012) Alzheimer’s disease and amyloid: Culprit or coincidence? International Review of Neurobiology, 102, 277-316. doi:10.1016/B978-0-12-386986-9.00011-9

[8]   Swerdlow, R.H. (2012) Alzheimer’s disease pathologic cascades: Who comes first, what drives what. Neurotoxicity Research, 22, 182-194. doi:10.1007/s12640-011-9272-9

[9]   Marques, S.C., Oliveira. C.R., Outeiro. T.F. and Pereira. C.M. (2010) Alzheimer’s disease: The quest to understand complexity. Journal of Alzheimers Disease, 21, 373-383.

[10]   Mullane, K. and Williams, M. (2013) Alzheimer’s therapeutics: Continued clinical failures question the validity of the amyloid hypothesis—But what lies beyond? Biochemical Pharmacology, 85, 289-305. doi:10.1016/j.bcp.2012.11.014

 
 
Top